Gujarat Themis Biosyn Intrinsic Value
Gujarat Themis Biosyn (GUJTHEM) median intrinsic value is ₹327.27 from 10 valuation models (range ₹128–₹727), vs current price ₹427.40 — -23.4% downside (Trading Above Calculated Value), margin of safety -30.6%. For current market price and key ratios, visit Gujarat Themis Biosyn share price chart.
GUJTHEM Valuation Methods Summary — DCF, Graham Number & P/E
Gujarat Themis Biosyn intrinsic value across 10 models vs current price ₹427.40 — upside/downside and value range per method. See GUJTHEM P/B ratio history to compare market price against book value per share.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹128.22 | ₹102.58 - ₹153.86 | -70.0% | EPS: ₹4.00, Sector P/E: 22x |
| Book Value Method | asset | ₹523.64 | ₹471.28 - ₹576.00 | +22.5% | Book Value/Share: ₹261.82, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹327.27 | ₹294.54 - ₹360.00 | -23.4% | Revenue/Share: ₹163.64, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹727.27 | ₹654.54 - ₹800.00 | +70.2% | EBITDA: ₹80.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹416.86 | ₹333.49 - ₹500.23 | -2.5% | CF Growth: 5.2%, Discount: 15% |
| PEG Ratio Method | growth | ₹128.22 | ₹115.40 - ₹141.04 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹128.22 | ₹115.40 - ₹141.04 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹560.00 | ₹504.00 - ₹616.00 | +31.0% | ROE: 15.3%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹153.50 | ₹138.15 - ₹168.85 | -64.1% | EPS: ₹4.00, BVPS: ₹261.82 |
| Dividend Yield Method | dividend | ₹128.22 | ₹115.40 - ₹141.04 | -70.0% | DPS: ₹0.67, Target Yield: 2.5% |
GUJTHEM Intrinsic Value vs Market Price — All Valuation Models
Gujarat Themis Biosyn fair value range ₹128–₹727 vs current market price ₹427.40 across 10 valuation models. Check GUJTHEM market capitalization to track the company's total market size over time.
GUJTHEM Intrinsic Value Analysis — Undervalued or Overvalued?
Gujarat Themis Biosyn median intrinsic value ₹327.27, current price ₹427.40 — Trading Above Calculated Value by 23.4%, margin of safety -30.6%.
What is the intrinsic value of GUJTHEM?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Gujarat Themis Biosyn (GUJTHEM) is ₹327.27 (median value). With the current market price of ₹427.40, this represents a -23.4% variance from our estimated fair value.
The valuation range spans from ₹128.22 to ₹727.27, indicating ₹128.22 - ₹727.27.
Is GUJTHEM undervalued or overvalued?
Based on our multi-method analysis, Gujarat Themis Biosyn (GUJTHEM) appears to be trading above calculated value by approximately 23.4%.
GUJTHEM Financial Health — Key Ratios vs Industry Benchmarks
Gujarat Themis Biosyn financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.65 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 15.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 44.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.36x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
GUJTHEM Cash Flow Quality — Operating & Free Cash Flow
Gujarat Themis Biosyn operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹49 Cr | ₹-37 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹91 Cr | ₹35 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹64 Cr | ₹37 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹40 Cr | ₹30 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹40 Cr | ₹25 Cr | Positive Free Cash Flow | 8/10 |